News Release

Active HIV in large white blood cells may drive cognitive impairment in infected mice

Study surfaces new evidence of an important role for macrophages in HIV-related cognitive impairment

Peer-Reviewed Publication

PLOS

Active HIV in Large White Blood Cells May Drive Cognitive Impairment in Infected Mice

image: Brains are composed of different cell types and the image from microscopy shows what cells EcoHIV infects in a mixture of mouse brain cells in tissue culture. The colors label specific elements in the cell mixture: blue shows DNA found in all cells, red shows a specific protein CD11b that is found in microglia, the brain cell related to macrophages found in other tissues, and green shows a marker inserted in EcoHIV to make it easier to see. The only areas with green are also colored red that together make bright orange. This means that the only cells infected by green EcoHIV are red, that is microglia. The cells that are not stained by red, either brain neurons or astrocytes, are not EcoHIV infected. This image thus demonstrates that EcoHIV infects mouse brain microglial cells, a process that we believe is responsible for induction of cognitive impairment by EcoHIV in mice. The image was obtained by Dr. Boe-Hyun Kim in Volsky lab, The Icahn School of Medicine at Mount Sinai, New York. view more 

Credit: Gu et al (2018)

Macrophages, large white blood cells that engulf and destroy potential pathogens, harbor active viral reserves that appear to play a key role in impaired learning and memory in mice infected with a rodent version of HIV. Chao-Jiang Gu of Icahn School of Medicine at Mount Sinai, New York, and colleagues present these new findings in PLOS Pathogens.

Drug combinations known as antiretroviral therapy have been very successful in suppressing the effects of HIV in infected people. However, about 50 percent of people on long-term antiretroviral therapy still experience HIV-related learning and memory problems. Exactly how HIV causes these problems is unclear.

To investigate the role of HIV in neurocognitive impairment, Gu and colleagues infected mice with a genetically engineered rodent version of HIV known as EcoHIV. They found that the mice's immune systems were able to suppress EcoHIV levels and EcoHIV complications; similar effects are seen in response to antiretroviral therapy in humans. As in humans, the mice nonetheless experienced learning and memory problems.

The researchers found that, similarly to humans, the infected mice harbored dormant viral reserves in immune system T cells. However, despite the mice's robust immune systems, the virus also appeared at low levels in the brain, and actively replicating EcoHIV was found in macrophages. When mice lacking T cells were infected with EcoHIV, they still experienced cognitive problems, suggesting that the infected macrophages were enough to drive this impairment.

These findings add to growing evidence that macrophages harboring active HIV may transport HIV to the brain, leading to cognitive problems in infected people. The researchers suggest that EcoHIV infection of mice could serve as a powerful and versatile research tool for further investigation of these effects and development of strategies to prevent them.

Dr. Volsky added: "Cognitive impairment is a common problem in a wide variety of human conditions including diabetes, aging, and Alzheimer's Disease. Studies in the EcoHIV model of cognitive impairment may have broad implications for better understanding and treatment of these conditions as well".

###

In your coverage please use this URL to provide access to the freely available article in PLOS Pathogens: http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1007061

Citation: Gu C-J, Borjabad A, Hadas E, Kelschenbach J, Kim B-H, Chao W, et al. (2018) EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment. PLoS Pathog 14(6): e1007061. https://doi.org/10.1371/journal.ppat.1007061

Funding: This work was supported by grants DA017618, DA037611, DA041931, and MH104145 to DJV and grant NS94146 to MJP from the National Institutes of Health, US Public Health Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.